APA
Abelson A., Delgado-Vega A. M., Kozyrev S. V., Sánchez E., Velázquez-Cruz R., Eriksson N., Wojcik J., Linga Reddy M. V. P., Lima G., D'Alfonso S., Migliaresi S., Baca V., Orozco L., Witte T., Ortego-Centeno N., Abderrahim H., Pons-Estel B. A., Gutiérrez C., Suárez A., González-Escribano M. F., Martin J. & Alarcón-Riquelme M. E. (20091117). STAT4 associates with systemic lupus erythematosus through two independent effects that correlate with gene expression and act additively with IRF5 to increase risk. : Annals of the rheumatic diseases.
Chicago
Abelson A-K, Delgado-Vega A M, Kozyrev S V, Sánchez E, Velázquez-Cruz R, Eriksson N, Wojcik J, Linga Reddy M V P, Lima G, D'Alfonso S, Migliaresi S, Baca V, Orozco L, Witte T, Ortego-Centeno N, Abderrahim H, Pons-Estel B A, Gutiérrez C, Suárez A, González-Escribano M F, Martin J and Alarcón-Riquelme M E. 20091117. STAT4 associates with systemic lupus erythematosus through two independent effects that correlate with gene expression and act additively with IRF5 to increase risk. : Annals of the rheumatic diseases.
Harvard
Abelson A., Delgado-Vega A. M., Kozyrev S. V., Sánchez E., Velázquez-Cruz R., Eriksson N., Wojcik J., Linga Reddy M. V. P., Lima G., D'Alfonso S., Migliaresi S., Baca V., Orozco L., Witte T., Ortego-Centeno N., Abderrahim H., Pons-Estel B. A., Gutiérrez C., Suárez A., González-Escribano M. F., Martin J. and Alarcón-Riquelme M. E. (20091117). STAT4 associates with systemic lupus erythematosus through two independent effects that correlate with gene expression and act additively with IRF5 to increase risk. : Annals of the rheumatic diseases.
MLA
Abelson A-K, Delgado-Vega A M, Kozyrev S V, Sánchez E, Velázquez-Cruz R, Eriksson N, Wojcik J, Linga Reddy M V P, Lima G, D'Alfonso S, Migliaresi S, Baca V, Orozco L, Witte T, Ortego-Centeno N, Abderrahim H, Pons-Estel B A, Gutiérrez C, Suárez A, González-Escribano M F, Martin J and Alarcón-Riquelme M E. STAT4 associates with systemic lupus erythematosus through two independent effects that correlate with gene expression and act additively with IRF5 to increase risk. : Annals of the rheumatic diseases. 20091117.